GCM
RGEN icon

Geneva Capital Management’s Repligen RGEN Stock Holding History

Geneva Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.5M Sell
656,093
-37,645
-5% -$4.63M 2.05% 13
2026
Q1 		$81.7M Buy
693,738
+130,763
+23% +$18.3M 1.74% 20
2025
Q4 		$92.2M Sell
562,975
-33,793
-6% -$5.29M 1.73% 18
2025
Q3 		$79.8M Buy
596,768
+109,234
+22% +$13.3M 1.37% 23
2025
Q2 		$60.6M Buy
487,534
+343,991
+240% +$43.8M 1.02% 36
2025
Q1 		$18.3M Buy
143,543
+7,958
+6% +$1.22M 0.34% 76
2024
Q4 		$19.5M Sell
135,585
-3,092
-2% -$443K 0.34% 80
2024
Q3 		$20.6M Buy
138,677
+10,908
+9% +$1.56M 0.34% 84
2024
Q2 		$16.1M Buy
127,769
+9,051
+8% +$1.42M 0.29% 85
2024
Q1 		$21.8M Sell
118,718
-1,449
-1% -$276K 0.38% 78
2023
Q4 		$21.6M Buy
120,167
+2,164
+2% +$337K 0.41% 75
2023
Q3 		$18.8M Sell
118,003
-5,603
-5% -$916K 0.4% 79
2023
Q2 		$17.5M Sell
123,606
-6,547
-5% -$1.05M 0.34% 82
2023
Q1 		$21.9M Buy
130,153
+1,088
+0.8% +$194K 0.45% 73
2022
Q4 		$21.9M Sell
129,065
-12,348
-9% -$2.24M 0.49% 73
2022
Q3 		$26.5M Sell
141,413
-1,996
-1% -$421K 0.61% 64
2022
Q2 		$23.3M Sell
143,409
-210
-0.1% -$33.2K 0.54% 70
2022
Q1 		$27M Buy
143,619
+18,582
+15% +$3.53M 0.52% 80
2021
Q4 		$33.1M Buy
125,037
+7,404
+6% +$1.99M 0.53% 77
2021
Q3 		$34M Sell
117,633
-5,915
-5% -$1.52M 0.58% 75
2021
Q2 		$24.7M Sell
123,548
-4,404
-3% -$854K 0.4% 90
2021
Q1 		$24.9M Sell
127,952
-29,949
-19% -$6.14M 0.42% 89
2020
Q4 		$30.3M Sell
157,901
-18,822
-11% -$3.42M 0.51% 81
2020
Q3 		$26.1M Buy
176,723
+14,619
+9% +$2.09M 0.54% 74
2020
Q2 		$20M Buy
162,104
+78,502
+94% +$9.24M 0.43% 87
2020
Q1 		$8.07M Buy
+83,602
New +$8.07M 0.23% 100

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geneva Capital Management's RGEN Position: Q2 2026 in Review

Geneva Capital Management reduced its Repligen (RGEN) stake by 5.4% in Q2 2026, selling an estimated $4.63M and leaving 656,093 shares worth $89.5M. The position accounts for 2.05% of the portfolio, ranked #13.

Geneva Capital Management first reported a position in RGEN in Q1 2020 and has held it in 26 quarters since. The position peaked at $92.2M in Q4 2025. 480 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Geneva Capital Management held 656,093 shares of Repligen worth $89.5M as of Q2 2026.
  • Geneva Capital Management sold 37,645 Repligen shares in Q2 2026, an estimated $4.63M.
  • Repligen made up 2.05% of Geneva Capital Management's portfolio in Q2 2026, its #13 holding.
  • Geneva Capital Management first reported a position in Repligen in Q1 2020 and has held it in 26 quarters since.
  • Geneva Capital Management's Repligen position peaked at $92.2M in Q4 2025.
  • 480 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.